Posticy
Boost your SEO with Backlinks that are worth it
SR Ranko
Turn scattered startup information into focused action.
SR Booster
Submit your startup to 120+ top directories.
  • Company

Company Rank

0

Country Rank

SR Score

0

SR Web

0

SR Social

0

CoLucid Pharmaceuticals is a biotechnology company focusing on therapies for central nervous system disorders.

Acquired by Eli Lilly on January 18, 2017

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world.

General Information and Guidelines:

Eli Lilly and Company strives to create informative and engaging online ...
See More

Website: https://www.colucid.com

Founded: January 01, 2005

 SR Traffic - Month

 Ahrefs

X

CoLucid Pharmaceuticals Competitors

Add Competitor

Startup Industry Description
24Genetics
Pharmaceuticals & Biotechnology DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
Turn Biotechnologies
Pharmaceuticals & Biotechnology Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...
NeuroX1
Pharmaceuticals & Biotechnology The new standard in computational neuroscience - NeuroX1 is a computational drug design company bui ...
View more competitors»

CoLucid Pharmaceuticals Funding

Add Funding

Date Round Amount Investors
Jan 13, 2015 Series C $ 37,100,000
Aug 30, 2011 Venture $ 7,500,000
Mar 03, 2011 Debt Financing $ 2,000,000
View more funding rounds»

CoLucid Pharmaceuticals Acquisitions

Add Acquisition

Date Acquired Amount
There are no acquisitions.

CoLucid Pharmaceuticals Products

Add Product

Product Stage Description
There are no products.

CoLucid Pharmaceuticals Team

Add Team Member

Person Role Period
James F. White
Founder Unknown to Unknown

CoLucid Pharmaceuticals News

Add News

Date Title
There are no news.

CoLucid Pharmaceuticals Statistics

Last Week

Rank

SR Score

Likes

Followers



Last Month

Rank

SR Score

Likes

Followers